Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
AtaiBeckley Inc. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
ATAI
Nasdaq
2830
www.ataibeckley.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for AtaiBeckley Inc.
Assessing AtaiBeckley (ATAI) Valuation After Trial Success Index Addition Capital Raise And US Move
- Jan 21st, 2026 11:14 am
The Bull Case For AtaiBeckley (ATAI) Could Change Following Promising BPL-003 Phase 2b Depression Data
- Jan 20th, 2026 12:48 pm
High Risk, High Reward: 3 Healthcare Stocks to Watch in 2026
- Jan 19th, 2026 9:28 am
Atai Beckley N.V. (ATAI) Achieves Significant Milestone on Pipeline Development and Corporate Foundation
- Jan 18th, 2026 10:30 am
AtaiBeckley Participates in the 64th Annual ACNP Meeting with Two Scientific Poster Presentations and Hot Topic Presentation
- Jan 16th, 2026 5:00 am
Atai Beckley N.V. (ATAI) is a Buy on Mental Therapeutics Opportunities
- Jan 14th, 2026 12:13 pm
Is It Too Late To Consider AtaiBeckley (ATAI) After A 145% One-Year Surge?
- Jan 9th, 2026 1:10 pm
Atai Beckley CEO says entering 2026 with ‘meaningful momentum’
- Jan 9th, 2026 5:17 am
AtaiBeckley Provides Update and Outlook for 2026 Ahead of J.P. Morgan Healthcare Conference
- Jan 8th, 2026 5:00 am
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
- Jan 4th, 2026 2:51 pm
AtaiBeckley Completes Redomiciliation to the United States
- Dec 30th, 2025 5:13 pm
JonesTrading Highlights Differentiated Pipeline at Atai Beckley N.V. (ATAI)
- Dec 27th, 2025 5:43 am
Atai Life Sciences (ATAI): Assessing an Expensive-Looking Valuation After a Strong Share Price Run
- Dec 25th, 2025 1:06 pm
The 1 Riskiest Investment That Paid Off in 2025
- Dec 25th, 2025 6:30 am
Coty downgraded, Spruce Biosciences initiated: Wall Street's top analyst calls
- Dec 23rd, 2025 7:33 am
AtaiBeckley Added to the Nasdaq Biotechnology Index (NBI)
- Dec 23rd, 2025 5:00 am
MarketBeat’s Top 5 Rated Small-Cap Stocks
- Dec 22nd, 2025 11:12 am
Atai Life Sciences N.V. (ATAI) Secures Patent for Social Anxiety Disorder Formulation
- Dec 18th, 2025 1:14 am
AtaiBeckley Announces New U.S. Patent Granted for EMP-01, Strengthening Intellectual Property Portfolio
- Dec 11th, 2025 5:00 am
Atai Life Sciences (ATAI): Assessing an 8.8x Price-to-Book Valuation After a Volatile Share Price Run
- Dec 3rd, 2025 2:14 pm
Scroll